Biogen (BIIB) Revenue — Quarter Ended Sep 30, 2023
Biogen's revenue for the quarter increased both sequentially and compared to the same quarter a year ago. The company completed a large acquisition during the period, which may affect future results.
Key takeaway
Quarter ended Sep 30, 2023 · FY2023 Q3
Biogen's revenue for the quarter increased both sequentially and compared to the same quarter a year ago. The company completed a large acquisition during the period, which may affect future results.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$2.5B
Revenue reported for this quarter.
Quarter-over-quarter
+3.0%
Change from the immediately preceding quarter.
Year-over-year
+0.9%
Change from the comparable year-ago quarter.
Trailing four quarters
$10B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Dec 31, 2022 | $2.5B | -6.9% |
| Mar 31, 2023 | $2.5B | -4.9% |
| Jun 30, 2023 | $2.5B | -5.1% |
| Sep 30, 2023 | $2.5B | +0.9% |
Revenue performance
Revenue grew slightly from the prior quarter, reflecting a modest sequential uptick. Compared to the same period last year, revenue also showed a small increase.
Quarterly comparison
The sequential growth was moderate, while the year-over-year gain was even more modest. Both comparisons indicate a stable revenue trend.
What to watch
The impact of the recently completed Reata acquisition on future revenue will be a key focus.